IMMP News & Events

Latest data shows the largest indicative borrow rate increases among liquid option names include: Immutep Ltd (IMMP) 117.72% +5.51, Merlin Inc (MRLN) 86.35% +3.04, T-REX 2X Long BMNR Daily Target ETF (BMNU) 18.58% +0.98, PROSHARES ULTRA BITCOIN ETF (BITU) 8.22% +0.65, CrowdGather Inc (CRWG) 8.91% +0.51, iShares Germany (EWG) 8.37% +0.50, LAR Stock (LAR) 1.98% +0.50, Canadian Natural (CNQ) 0.76% +0.46, ProShares UltraShort QQQ (QID) 2.60% +0.45, and Red Cat Holdings (RCAT) 2.05% +0.43.

Immutep advises that it has received a written notification from Nasdaq regarding non-compliance with the Nasdaq minimum bid price requirement. Nasdaq Listing Rule 5450 requires listed securities to maintain a minimum bid price of $1.00 per share. Based on the closing bid price of the company's American depositary shares for the 30 consecutive business days ended April 24, the company does not currently meet this requirement.

Immutep announced that the FDA has granted Orphan Drug Designation for eftilagimod alfa for the treatment of Soft Tissue Sarcoma.